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SUMMARY

Receptor-mediated oscillations in cytosolic Ca2+
concentration ([Ca2+]i) could originate either directly
from an autonomous Ca2+ feedback oscillator at
the inositol 1,4,5-trisphosphate (IP3) receptor or as
a secondary consequence of IP3 oscillations driven
by Ca2+ feedback on IP3 metabolism. It is challenging
to discriminate these alternatives, because IP3 fluctuations could drive Ca2+ oscillations or could just
be a secondary response to the [Ca2+]i spikes. To
investigate this problem, we constructed a recombinant IP3 buffer using type-I IP3 receptor ligand-binding domain fused to GFP (GFP-LBD), which buffers
IP3 in the physiological range. This IP3 buffer slows
hormone-induced [IP3] dynamics without changing
steady-state [IP3]. GFP-LBD perturbed [Ca2+]i oscillations in a dose-dependent manner: it decreased
both the rate of [Ca2+]i rise and the speed of Ca2+
wave propagation and, at high levels, abolished
[Ca2+]i oscillations completely. These data, together
with computational modeling, demonstrate that IP3
dynamics play a fundamental role in generating
[Ca2+]i oscillations and waves.
INTRODUCTION
Oscillatory Ca2+ signaling is a fundamental control process
utilized by hormones and other agonists linked to the second
messenger inositol 1,4,5-trisphospate (IP3). Stimulus strength
is typically encoded by increasing the frequency of cytosolic
Ca2+ ([Ca2+]i) oscillations. For example, in hepatocytes, baseline-separated [Ca2+]i oscillations with an extended frequency
range (seconds to many minutes) provide fine control of metabolic output over log-order hormone dose ranges (Bartlett
et al., 2014; Hajnóczky et al., 1995; Rooney et al., 1989; Woods
et al., 1986). Despite their critical importance, the mechanisms

underlying IP3-dependent [Ca2+]i oscillations have not been fully
elucidated (Berridge, 1993; Dupont et al., 2011; Meyer and
Stryer, 1988; Thomas et al., 1996; Thurley and Falcke, 2011).
There are two distinct classes of apparently opposing hypotheses that are very difficult to distinguish experimentally: Ca2+
excitability models in which Ca2+ oscillations occur independent
of IP3 oscillations and cross-coupling models whereby IP3 oscillations are required to drive periodic Ca2+ release and reuptake.
In Ca2+ excitability hypotheses, feedback regulation by Ca2+
release from the ER gives rise to oscillations in [Ca2+]i, with IP3
serving as an upstream trigger that does not need to oscillate
itself (i.e., [Ca2+]i oscillations can occur at constant [IP3]). The
complex regulatory properties of the IP3 receptor Ca2+ release
channel (IP3R) provided a specific mechanism for Ca2+ excitability of the ER (De Young and Keizer, 1992; Hajnóczky and
Thomas, 1997). Feedback activation through [Ca2+]i can cause
the coordinated opening of IP3Rs and regenerative Ca2+ release
from the ER via a Ca2+-induced Ca2+ release (CICR) mechanism,
whereas delayed negative feedback by Ca2+ can result in the
subsequent closing of IP3Rs and the return of [Ca2+]i to baseline
through the action of Ca2+ pumps (Dupont and Goldbeter, 1993;
Thomas et al., 1996; Wakui et al., 1989). Thus, the sequential
Ca2+-dependent activation and inactivation of IP3Rs can give
rise to an autonomous oscillator that generates periodic [Ca2+]i
spikes. Mathematical models based solely on IP3R kinetics yield
[Ca2+]i oscillations that occur at high frequency (seconds) and
within a limited range of [IP3] or phospholipase-C (PLC) activity
(De Young and Keizer, 1992). Experimental evidence supports
the existence of such a fast [Ca2+]i oscillator mechanism in
some cell types, activated by a static increase in average [IP3]
(Keizer et al., 1995; Lechleiter and Clapham, 1992; Sneyd
et al., 2006).
In many other cell types, however, [Ca2+]i signals evoked with
physiologically relevant agonist doses have much lower frequencies (of the order of minutes) than the oscillations based
on periodic IP3R opening (Bartlett et al., 2014; Harootunian
et al., 1991; Osipchuk et al., 1990; Politi et al., 2006; Rooney
et al., 1989; Woods et al., 1986). In hepatocytes, the slow
[Ca2+]i oscillations observed in hormone-stimulated intact cells
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revert to a higher frequency spiking pattern when studied at fixed
[IP3] after cell permeabilization (Hajnóczky and Thomas, 1997).
Thus, other mechanisms may be superimposed on the basic
Ca2+ excitability model to produce the broad distribution of
agonist-evoked [Ca2+]i oscillation frequencies observed experimentally. This can provide more efficient encoding of the
strength of the extracellular stimulus into intracellular Ca2+
signaling (Politi et al., 2006).
Cross-coupling hypotheses postulate that the dynamics of
IP3 and Ca2+ are mutually destabilizing, resulting in coupled
oscillations of both messengers. In the most widely discussed
model, stimulation of PLC by Ca2+ provides the positive feedback to generate a rapid burst of IP3 formation (Harootunian
et al., 1991; Meyer and Stryer, 1988; Politi et al., 2006; Woods
et al., 1986). Termination of Ca2+ release can occur by negative
feedback processes such as Ca2+ inactivation of IP3R, elimination of IP3 by Ca2+activation of inositol 1,4,5-trisphosphate
3-kinase (ITPK), or inhibition of receptor-stimulated PLC by
protein kinase C (PKC). Thus, Ca2+-dependent feedback on
either PLC, ITPK, or PKC, alone or in combination, has the
potential to generate oscillations in [IP3] and drive [Ca2+]i
spiking (Politi et al., 2006).
Consistent with cross-coupling models, [Ca2+]i spiking has
been shown to be accompanied by synchronous fluctuations
in IP3 or phosphatidylinositol 4,5-bisphosphate levels in intact
cells (Harootunian et al., 1991; Hirose et al., 1999; Matsu-ura
et al., 2006; Várnai and Balla, 1998). This may be an indication
that IP3-Ca2+ cross-coupling is involved in the regulation of
[Ca2+]i oscillations. However, an alternative interpretation would
be that the IP3 fluctuations are an epiphenomenon mediated by
Ca2+-dependent changes in IP3 metabolism and are nonessential for generating [Ca2+]i oscillations (Dupont et al., 2003; Tanimura et al., 2009). We have taken a different approach from
trying to measure IP3 oscillations and correlate [IP3] changes
with [Ca2+]i oscillations, focusing instead on modifying IP3
dynamics with a genetically encoded IP3 buffer designed to
function within the physiological range of [IP3]. The recombinant
cytosolic IP3 buffer was constructed by the in-frame fusion of the
N-terminal 620 amino acids of the type-I IP3R to the C terminus
of green or red fluorescent protein (GFP-LBD or DsRed-LBD).
Previous studies have shown that the N terminus of the IP3R
expressed in E. coli can bind to IP3 with similar affinity to native
IP3R (Yoshikawa et al., 1996).
Chemical Ca2+ buffers and recombinantly expressed Ca2+binding proteins have been successfully employed to investigate
the role of Ca2+ dynamics in numerous processes. IP3-binding
proteins should prove equally useful to probe the role of IP3 dynamics in generating Ca2+ spikes. The expression of GFP-LBD
is expected to slow the kinetics of agonist-evoked IP3 turnover
without modifying the free steady-state [IP3]. Moreover, our
modeling studies demonstrate that an IP3 buffer allows us to
go beyond determining the causality between [IP3] and [Ca2+]i
oscillations; it is also an ideal experimental tool to distinguish
between positive- versus negative-feedback effects of Ca2+ on
IP3 metabolism in controlling the generation of oscillatory Ca2+
signals (Politi et al., 2006).
The data presented here show that GFP-LBD can bind IP3
and decrease the rate of IP3 rise during agonist stimulation,

which disrupts [Ca2+]i spikes in COS cells and primary hepatocytes. This perturbation of Ca2+ signaling was due to the ability
of GFP-LBD to bind IP3, because a mutant that does not bind
IP3 had no effect on agonist-induced [Ca2+]i responses.
Increasing the level of GFP-LBD expression correlated with a
loss of repetitive Ca2+ spiking and the appearance of distorted
[Ca2+]i responses with slower kinetics and smaller amplitudes.
These data suggest that [IP3] increased to a level sufficient
to activate the IP3R but lacked a self-amplifying mechanism
required for robust spikes of Ca2+ release and propagation
of intracellular [Ca2+]i waves. Finally, introducing an IP3
buffer into a mathematical model based on the positive feedback of Ca2+ on PLC reproduced the experimental data.
Taken together, these findings provide strong evidence that
dynamic fluctuations of IP3 are an essential component in the
generation of [Ca2+]i spikes and propagation of intracellular
Ca2+ waves.
RESULTS
Expression of GFP-LBD in COS Cells
The properties of GFP-LBD were determined in COS cells
transiently transfected with either GFP alone, GFP-LBD, or a
nonbinding mutant of GFP-LBD, with a single amino acid substitution in the IP3-binding site (GFP-R265QLBD; Yoshikawa et al.,
1996). Western blot analysis of cells transfected with GFP-LBD
or GFP-R265QLBD revealed a band at 100 kDa, which corresponds to the full-length fusion protein (Figure S1A). Confocal
images of COS cells expressing GFP-LBD or GFP-R265QLBD
revealed a cytosolic distribution, similar to that observed with
GFP (Figure S1B). Permeabilization of the plasma membrane
with digitonin resulted in rapid loss of the GFP fusion proteins,
suggesting they are not bound to cytoskeletal elements or
organelles.
Although GFP-LBD appeared to be freely diffusible, it could
potentially interact with endogenous proteins, including plasma
membrane and intracellular ion channels, and thereby modify
agonist-induced Ca2+ influx and/or ER Ca2+ content. To test
these possibilities, COS cells expressing GFP, GFP-LBD, or
GFP-R265QLBD were incubated in Ca2+-free medium and
the ER Ca2+ stores were released by treatment with 50 mM
cyclopiazonic acid (CPA), followed by addition of 1.5 mM
CaCl2 to measure store-operated Ca2+ influx (Figures S1C–
S1E). GFP-LBD did not affect the size of the Ca2+ store, monitored by the rate and magnitude of CPA-induced Ca2+ release,
and did not alter the rate or amplitude of Ca2+ influx elicited
by subsequent Ca2+ add back (Figures S1C–S1E). Similar results
were obtained with the purinergic agonist ATP. GFP-R265QLBD
also had no effect on intracellular Ca2+ release or Ca2+ influx (Figures S1F and S1G). Finally, there was no effect of GFP-LBD on
resting [Ca2+]i, indicating that it did not alter basal [Ca2+]i homeostasis in the absence or presence of extracellular Ca2+ (Figures
S1D and S1H). Similar results were obtained in hepatocytes
(Figure S2A).
Because the intracellular concentration of the IP3 buffer
is an important parameter for our analysis, we used a standard curve constructed with recombinant GFP to estimate
the cytoplasmic concentration of each fusion protein on a
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Figure 1. Effects of GFP-LBD and GFP-R265QLBD on Agonist-Induced Ca2+ Signals in COS Cells
COS cells transfected with GFP, GFP-LBD, or GFP-R265QLBD were loaded with fura-2 and then stimulated with ATP (arrowheads).
(A–D) Traces are typical ATP-induced [Ca2+]i responses in nonexpressing (A and C) and expressing (B and D) cells on the same coverslips.
(E and F) The amplitude (E) and rate of rise (F) of [Ca2+]i spikes induced by submaximal and maximal ATP are summarized for cells expressing GFP, GFP-LBD,
or nonexpressing cells (none). Data are mean ± SEM from six separate experiments (n = 10–14 cells/group). *p < 0.05.
(G–I) Bottom traces show [Ca2+]i responses to stepwise increases in ATP in cells expressing nothing (G), GFP-LBD (H), or GFP-R265QLBD (I).

cell-by-cell basis, as described previously (Politi et al., 2006).
The mean levels of intracellular expression in COS cells for
GFP-LBD and GFP-R265QLBD were similar (13 ± 1 mM and
12 ± 1 mM, respectively), whereas GFP alone was expressed
at somewhat higher levels (22 ± 1 mM; see Table S1). As
expected, there was an increase in the amount of total IP3
binding measured in lysates prepared from populations of
COS cells transfected with GFP-LBD compared to GFP alone
(79 ± 6 versus 20 ± 1 fmoles of IP3/mg cell protein, respectively, at 9.6 nM 3H-IP3).
These data demonstrate that the ligand-binding domain of
GFP-LBD is expressed in the correct confirmation and is able
to bind IP3. In addition, GFP-LBD does not modify the activity
of plasma membrane Ca2+ channels, the size of internal Ca2+
stores, or the basal levels of [Ca2+]i.

GFP-LBD Blocks Agonist-Induced [Ca2+]i Oscillations
in COS Cells
COS cells were transiently transfected with either GFP-LBD or
GFP, and the [Ca2+]i responses to ATP stimulation at submaximal (1 mM) and then maximal (100 mM) doses were monitored
with fura-2. Data from both expressing and nonexpressing cells
were recorded simultaneously from the same microscope field.
Figure 1 shows representative single-cell Ca2+ traces from
coverslips transfected with either GFP (Figures 1A and 1B) or
GFP-LBD (Figures 1C and 1D); in each case, the top panels
show responses for untransfected cells from the same field as
the transfected cell responses shown in the middle panels.
Data are summarized in Figures 1E and 1F. The addition of
1 mM ATP elicited periodic, baseline-separated [Ca2+]i oscillations in >90% of the COS cells that did not express the transgene
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Figure 2. Effects of GFP-LBD on HormoneInduced Ca2+ Signals in Hepatocytes
Hepatocytes transfected with GFP or GFP-LBD
were loaded with fura-2.
(A) VP-induced [Ca2+]i increases in cells expressing GFP and low or high levels of GFP-LBD ([GFP]
given under plots; see Table S1 for mean data).
(B) Percentage of cells showing the indicated Ca2+
response to submaximal hormone; n = 6 cell
preparations.
(C) Mean width of VP-induced [Ca2+]i spikes at half
peak height as a function of [GFP].
(D) Green and red traces show [Ca2+]i spikes at
proximal and distal subcellular regions along the
Ca2+ wave-propagation vector during 2 nM VP
stimulation; vector lengths were 15.5 mm (i),
16.8 mm (ii), and 19.2 mm (iii). Fluorescence was
normalized to initial and peak intensity.
(E and F) Effects of GFP-LBD on rates of Ca2+
wave propagation and [Ca2+]i rise in response to
submaximal and maximal hormone. Data are
mean ± SEM (six cell preparations). *Significantly
different from GFP-expressing cells; black diamond, significantly different from GFP and lowGFP-LBD-expressing cells; p < 0.05.

(Figures 1A and 1C) or expressed only GFP (Figure 1B). The
kinetics and amplitude of these [Ca2+]i oscillations remained
constant for the 10 min stimulation period and were not affected
by the expression of GFP. By contrast, expression of GFP-LBD
eliminated baseline-separated [Ca2+]i oscillations in response
to submaximal ATP; instead, a slow monophasic increase in
[Ca2+]i was observed (Figure 1D). The amplitude (Figure 1E)
and rate of [Ca2+]i increase (Figure 1F) in these cells were significantly lower following submaximal ATP stimulation when
compared to nonexpressing or GFP-positive cells.
Maximal ATP concentrations (100 mM) evoked a sustained increase in [Ca2+]i in both expressing and nonexpressing COS
cells transfected with either GFP or GFP-LBD (Figure 1). The
mean amplitude and rate of rise of these [Ca2+]i increases were
larger than those observed with 1 mM ATP (Figures 1E and 1F).
There were no significant differences between any of the groups
in the amplitude of the [Ca2+]i increase at 100 mM ATP, indicating
that, with sufficient stimulation, enough IP3 could be generated
to overcome the effect of the recombinant IP3 buffer. The
mean rate of [Ca2+]i increase in GFP-LBD-expressing cells was
slower than any of the control groups, but this parameter was
variable in the presence of GFP-LBD and was not statistically
significant.
To test whether the lack of baseline-separated [Ca2+]i oscillations in GFP-LBD-expressing COS cells was due to a shift in the
effective ATP sensitivity, we carried out dose-response studies

in these cells (Figure 1H). However,
[Ca2+]i oscillations were not observed at
any dose of ATP up to the maximum
that gave a sustained [Ca2+]i increase
equivalent to that in control cells. Instead,
low-amplitude monophasic [Ca2+]i increases were observed, the amplitude
of which increased in a dose-dependent manner. Frequencymodulated [Ca2+]i oscillations with similar amplitude and kinetics
to control cells were observed over the effective ATP dose range
in nonexpressing COS cells and cells expressing the nonbinding
mutant R265QLBD (Figures 1G and 1I). Thus, the suppression
of agonist-induced [Ca2+]i oscillations is a fundamental consequence of IP3 binding by GFP-LBD and not just due to a shift
in the effective free [IP3].
Taken together, these data demonstrate that GFP-LBD does
not prevent agonist-induced mobilization of Ca2+ from intracellular stores, even though it eliminates the ability of COS
cells to generate [Ca2+]i oscillations. The monotonic [Ca2+]i
increase evoked by agonist stimulation (Figures 1D and 1H)
indicates that IP3 levels were sufficient to activate the IP3R but
lacked a positive feedback mechanism required for rapid Ca2+
mobilization.
GFP-LBD Suppresses [Ca2+]i Oscillations
in Hepatocytes
Hepatocytes provide one of the most well-characterized examples of frequency-modulated [Ca2+]i oscillations in primary cells
and tissues, where they play a key role in the regulation of hepatic metabolism (Bartlett et al., 2014; Hajnóczky et al., 1995;
Thomas et al., 1996). Figure 2 shows the effects of GFP-LBD
expression on hormone-stimulated [Ca2+]i signaling in primary
cultures of rat hepatocytes. Figure 2A shows representative
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single-cell [Ca2+]i traces from hepatocytes expressing GFP or
different levels of GFP-LBD. GFP-LBD-positive cells were
divided into low- and high-expressing cells using a cutoff that
corresponded to a calculated intracellular GFP concentration
of 10 mM. The effects of GFP or GFP-LBD on the pattern of hormone-evoked [Ca2+]i responses are summarized in Figure 2B.
Stimulation of GFP-expressing hepatocytes with vasopressin
(VP) induced repetitive [Ca2+]i spiking that increased in frequency
in a dose-dependent manner until a sustained plateau of [Ca2+]i
was achieved (Figure 2A), consistent with the frequency modulation reported in previous studies (Rooney et al., 1989; Woods
et al., 1986). Submaximal VP (3 nM) evoked repetitive [Ca2+]i
spiking in 60% of the GFP-positive hepatocytes (Figure 2B)
with similar kinetic properties to those observed in untransfected
hepatocytes (Rooney et al., 1989). In both GFP- and GFP-LBDexpressing cells, the full scope of hormone-evoked Ca2+ responses was observed after hormone treatment, ranging from
no response through repetitive oscillations to peak and plateau
maximal increases in [Ca2+]i (Figure 2B). Importantly, in hepatocytes, baseline-separated [Ca2+]i spiking could be elicited by VP
in the presence of GFP-LBD. However, with increasing expression levels, GFP-LBD reduced the percentage of cells exhibiting
repetitive baseline-separated [Ca2+]i spikes (Figure 2B). In addition, there was a marked broadening of the individual [Ca2+]i
transients with increasing levels of the GFP-LBD IP3 buffer (Figure 2). In control (GFP-expressing) hepatocytes, the widths of
consecutive spikes remained constant, averaging 22 ± 1 s (n =
27 cells). The spike duration was significantly longer in GFPLBD-expressing hepatocytes, averaging 50 ± 7 s (p < 0.05; n =
21 cells). Moreover, the spike width in individual hepatocytes
correlated positively with the calculated GFP-LBD concentrations (R2 = 0.58), whereas there was no correlation between
spike width and GFP expression (R2 = 0.001; Figure 2C).
In the presence of high GFP-LBD (>10 mM), VP (1–3 nM) often
evoked a single, broad [Ca2+]i transient with a dramatically
slower rising phase (Figure 2A). The mean amplitude of these single-phasic [Ca2+]i increases in the presence of GFP-LBD was not
significantly different from GFP or nonexpressing controls (Figure S2A). Stepwise increases in VP concentration did not induce
amplitude-modulated [Ca2+]i increases in GFP-LBD-expressing
hepatocytes similar to those observed in COS cells (Figure 1).
Nevertheless, the broadening of the [Ca2+]i oscillations, slower
rate of rise (see below), and switch to a slow single-phasic transient in the presence of GFP-LBD all provide evidence that IP3
dynamics are a component of the Ca2+ oscillator that generates
baseline-separated Ca2+ spiking in hepatocytes.
In contrast to the baseline-separated [Ca2+]i spikes in hepatocytes and COS cells, ATP stimulation of MDA MB231 breast cancer cells causes high-frequency sinusoidal-like Ca2+ oscillations
(Figure S3). Expression of LBD in these cells did not affect the
[Ca2+]i oscillation frequency but did reduce the amplitude of
both the initial spike and subsequent oscillations (Figure S3).
Similar results were observed in the absence of extracellular
Ca2+, showing that the effects were not secondary to Ca2+ influx.
These data in MDA MB231 cells are consistent with the predicted effects of LBD on fast Ca2+ oscillations that can occur under conditions of constant [IP3], which typically occurs at high
levels of PLC activation (Politi et al., 2006). Thus, the effect of

IP3 buffering to suppress [Ca2+]i oscillations is primarily associated with long-period, baseline-separated Ca2+ spiking,
although this does not exclude a role for Ca2+ feedback on IP3
dynamics during faster oscillations.
The Effect of GFP-LBD on Intracellular [Ca2+]i Waves
In many cell types, [Ca2+]i oscillations are organized as intracellular Ca2+ waves. In hepatocytes, the Ca2+ waves begin at a
discrete subcellular locus associated with the apical membrane
and then propagate through the cell with constant velocity and
amplitude (Rooney et al., 1990). Figure 2D shows time courses
of [Ca2+]i increase at discrete subcellular sites following VP stimulation in GFP-, low-GFP-LBD, or high-GFP-LBD-expressing
hepatocytes. In each case, the green and red traces are the
[Ca2+]i increases from two subcellular regions in the same cell,
separated by similar distances (see legend). The effects of
GFP or GFP-LBD expression on the rates of Ca2+ wave propagation and rates of [Ca2+]i rise are summarized in Figures 2E and 2F.
Submaximal agonist concentrations were defined as those that
evoked oscillatory [Ca2+]i responses in GFP and low-GFPLBD-expressing cells, whereas maximal hormone doses evoked
a peak and plateau [Ca2+]i increase in all cells. In the GFP-expressing control cells, the rates of Ca2+ wave propagation and
rates of Ca2+ rise were not significantly different between submaximal and maximal hormone concentrations (Figures 2E and
S2C), consistent with our previous work showing that Ca2+
wave rates are independent of agonist dose (Rooney et al.,
1990). Increasing GFP-LBD expression from low to high levels
progressively slowed the rates of Ca2+ wave propagation and
decreased rates of Ca2+ rise elicited by submaximal hormone
stimulation (Figure 2). Maximal VP overcame the actions of low
levels of GFP-LBD expression on both [Ca2+]i oscillation parameters but only partially reversed the effects of high GFP-LBD
expression (Figures 2E and 2F). We also examined the effects
of LBD on the kinetics of Ca2+ waves using a recombinant
Ca2+-sensitive fluorescent protein, RGECO1 (Zhao et al.,
2011). This protein-based Ca2+ indicator is more slowly diffusible
with lower buffering capacity compared to fura-2, so it should
minimize alterations in Ca2+ wave kinetics that might derive
from indicator effects on Ca2+ diffusion. Nevertheless, the
expression of GFP-LBD still reduced Ca2+ wave velocity in a
stimulus-strength-dependent manner in our studies using
RGECO1 (Figures S2B and S2C). Thus, similar results were obtained with fura-2 and RGECO1: LBD decreased the rate of
[Ca2+]i rise even at subcellular resolution and slowed the propagation of Ca2+ waves. If [Ca2+]i oscillations and waves were
dependent only on Ca2+-feedback effects on Ca2+ release and
reuptake, independent of oscillations in IP3, the Ca2+ dynamics
should not be affected by the IP3 buffering effect of GFP-LBD.
Effect of LBD Expression on Ca2+ Responses Elicited by
Slow Release of Caged IP3
In order to further investigate whether the effects of IP3 buffering
on hormone-induced [Ca2+]i oscillations are indicative of a causative role for IP3 oscillations, we examined the response to a
slow, continuous uncaging of IP3. Progressive uncaging of IP3
with low-intensity UV illumination in the absence of hormone resulted in a monophasic [Ca2+]i rise after a brief delay, followed by
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Figure 3. Effect of GFP-LBD on [Ca2+]i
Response to Slow Uncaging of IP3
(A and B) Hepatocytes cotransfected with
RGECO1 and either GFP (A) or GFP-LBD (B) were
loaded with caged IP3 (2 mM; 1 hr). The gray area
shows the duration of slow IP3 uncaging elicited
by low-intensity UV illumination (50 ms exposures
at 2 Hz). VP was added at the arrow 5 min after
stopping UV illumination.
(C–E) Summary of the effects of GFP and GFPLBD on the rate of Ca2+ rise (C), peak amplitude
(D), and spike width (E). Data are mean ± SEM
(n R 50 cells from four separate experiments).
*Significantly different from GFP-expressing cells
(p < 0.05); #significantly different from control
(GFP) VP response; p < 0.05.

relative rates of IP3R Ca2+ activation and
inactivation. Instead, the data support
a role for rapid dynamic modulation of
IP3 levels specifically during hormoneinduced [Ca2+]i oscillations.

a slow return to basal. Figure 3 shows representative traces
from GFP- and GFP-LBD-expressing hepatocytes coexpressing
RGECO1 for [Ca2+]i measurement. Importantly, there was no
effect of LBD on the rate of rise (Figure 3C) or the peak amplitude
(Figure 3D) of the [Ca2+]i increase elicited by uncaging IP3.
One interpretation of these data is that once the [IP3] crosses a
critical threshold, the primary driver of [Ca2+]i increase is CICR,
yielding a Ca2+ transient that is essentially autonomous from
the slowly rising IP3 level. Despite the lack of effect of LBD on
the rising phase, it significantly prolonged the [Ca2+]i spike width
(Figure 3E), perhaps because it slows IP3 degradation. Once
the [Ca2+]i response to IP3 uncaging had returned to basal, the
hepatocytes were subsequently challenged with 1 nM VP. In
contrast to the results with IP3 uncaging, the rates of rise and
peak amplitude of VP-induced Ca2+ transients were significantly
decreased in the presence of LBD (Figures 3C and 3D). These
data demonstrate that the effect of the IP3 buffer is not simply
a consequence of the rate of delivery of IP3 to the IP3R or the

Effect of GFP-LBD on AgonistInduced IP3 Increases
The effects of GFP-LBD expression on
intracellular IP3 levels were measured in
populations of COS cells using an IP3
mass assay. Stimulation with submaximal ATP (1 mM) for 60 s increased total
intracellular IP3 by 30% ± 1% above
basal in control GFP-expressing cells,
whereas IP3 accumulation in GFP-LBDexpressing cells was significantly greater
at 69% ± 5% above basal (p < 0.001). No
significant difference in the basal levels
of IP3 could be detected between the
two cell populations. The higher accumulation of total IP3 in the presence of
GFP-LBD is an expected consequence
of IP3 buffering, because the IP3 buffer creates an additional
cellular pool of sequestrated IP3.
To directly measure agonist-induced [Ca2+]i and IP3 changes
simultaneously by single-cell imaging, we used the recombinant
IP3-sensitive biosensor IRIS-1 (Matsu-ura et al., 2006) together
with the chemical Ca2+ indicator Indo-1. More than 90% of
nontransfected COS cells responded to increasing ATP concentrations with frequency-modulated [Ca2+]i spiking, whereas ATP
induced only sporadic [Ca2+]i spikes in the presence of IRIS-1
(Figure S4). This presumably reflects the effect of IP3 binding
by IRIS-1 and is consistent with the sensitivity of COS cells to
the IP3 buffering effects of GFP-LBD shown in Figure 1. In order
to examine the effect of the LBD buffer on IP3 dynamics,
a DsRed-LBD construct was used so that IRIS-1 and LBD
could be discriminated in cotransfected cells. Stimulation with
maximal ATP caused a sustained increase in [Ca2+]i and a robust
rise in the IRIS-1 emission ratio in both DsRed and DsRed-LBDexpressing cells (Figure S4C). DsRed-LBD did not alter the
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Figure 4. Effect of LBD on [Ca2+]i and IP3 Dynamics in Hepatocytes
Hepatocytes cotransfected with IRIS-1 and either DsRed or DsRed-LBD were loaded with Indo-1 and then stimulated with submaximal (1–5 nM VP) or maximal
(100 nM VP or 100 mM ATP) agonist.
(A) Simultaneous measurement of IP3 and [Ca2+]i oscillations.
(B) Expanded time course of single IP3 and [Ca2+]i transients in the presence of DsRed or DsRed-LBD.
(C and D) Kinetics of VP-induced [Ca2+]i oscillations in cells expressing IRIS-1 plus DsRed (DsRed) or IRIS-1 plus DsRed-LBD (LBD), compared to nonexpressing
cells on the same coverslips (None).
(E and F) Effect of DsRed-LBD on the rate and magnitude of IP3 formation measured with IRIS-1 in cells stimulated with submaximal and maximal agonist. Data
are mean ± SEM; n = 4–7 cells from five separate experiments. *Significantly different from nonexpressing cells; black diamond, significantly different from DsRed
and nonexpressing cells; black triangle, significantly different from DsRed-expressing cells; p < 0.05.

magnitude of [IP3] increase induced by maximal ATP but slowed
the rate of IP3 rise by about 5-fold (Figures S4D and S4E). As with
our measurements of total IP3 formation, this is what is predicted
for an IP3 buffer and serves to validate our approach using the
LBD-expression constructs to modify the kinetics of IP3. In common with GFP-LBD, DsRed-LBD completely eliminated the
occurrence of ATP-induced [Ca2+]i oscillations in COS cells.
Therefore, it was not possible to determine the effect of LBD
on [IP3] dynamics during [Ca2+]i spiking in these cells.
We also used IRIS-1 to examine the effects of DsRed-LBD
expression on IP3 and [Ca2+]i dynamics in hormone-stimulated
hepatocytes (Figure 4). At low levels of expression, IRIS-1 did
not block [Ca2+]i oscillations induced by submaximal VP but
slowed the rising phase of the [Ca2+]i spike (compare DsRed to
None in Figure 4C). This is expected because IRIS-1 is itself an
IP3 buffer, but fortunately, its buffering effect is not sufficient
to prevent the [Ca2+]i oscillations in hepatocytes. Importantly,
for each [Ca2+]i spike, there was a parallel transient increase in
the IRIS-1 emission ratio, indicating that Ca2+ and IP3 oscillations
are synchronized in hepatocytes (Figure 4A). The onset of the
[Ca2+]i and IP3 spikes appeared to occur simultaneously,
whereas peak [Ca2+]i was achieved while the IP3 level was still
rising (Figure 4B). The declining phase of the IP3 oscillations

clearly lagged behind the relaxation of the [Ca2+]i spike, and
this was also apparent in the longer peak duration for IP3 (Figures
4B and 4D). These data are consistent with positive feedback
of Ca2+ on IP3 generation (Politi et al., 2006). Coexpression of
the IP3 buffer DsRed-LBD with IRIS-1 slowed the rate of rise of
[IP3], and this was accompanied by a slowing and broadening
of the [Ca2+]i spike (Figure 4), similar to that observed with
GFP-LBD (Figures 2 and 3). Although DsRed-LBD expression
slowed the rates of [IP3] increase evoked by both submaximal
and maximal hormone stimulation, it did not alter the magnitude
of these IP3 increases (Figures 4E and 4F).
The data presented above demonstrate that the IP3 buffers
DsRed-LBD and GFP-LBD act to suppress [Ca2+]i oscillations
by slowing the rate of increase in free IP3 and not by inhibiting
IP3 formation. This is consistent with a key role for IP3 dynamics
in driving [Ca2+]i oscillations. It should be noted that IRIS-1 also
partially inhibited agonist-induced [Ca2+]i oscillations, even
though it has a lower affinity for IP3 than the type-I IP3R used
to derive the LBD-based IP3 buffers (Kd of 500 nM versus
40 nM, respectively; Matsu-ura et al., 2006; Yoshikawa et al.,
1996). These findings indicate that IRIS-1 (and presumably other
IP3 indicators) can interfere with Ca2+ dynamics by buffering
agonist-induced changes in IP3.
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Figure 5. Simulations of the Effect of GFP-LBD Expression in Mathematical Models of Ca2+/IP3 Oscillations
Ca2+ and IP3 oscillations were modeled as described in Supplemental Information in the absence (A–D) and presence (E–H) of LBD IP3 buffer. Parameters
used are given in Table S2. Stepwise agonist dose increases occur at each arrow. All models show frequency encoding of stimulus strength in the absence
of LBD. LBD does not abolish oscillations in models with PKC-mediated receptor/PLC inactivation (E) or Ca2+-dependent IP3 metabolism by ITPK (F). Ca2+
oscillations are abolished by LBD in models with Ca2+ activation of PLC (G and H). Graded plateau [Ca2+]i increases occur when the plasma membrane fluxes
are neglected (G), and slow broad [Ca2+]i transients occur when Ca2+ fluxes through the PMCA are substantial (H). LBD concentrations were 30 mM in (E), (F),
and (H) and 5 mM in (G).

Mathematical Modeling of IP3 Buffer Effects
on IP3-Induced Ca2+ Oscillators
The data presented here provide evidence that oscillations of
IP3 are essential for the generation of [Ca2+]i spiking in many
cell types. Different mechanisms for feedback regulation of
IP3 levels by Ca2+ ions have been proposed that can result
in coupled oscillations of [IP3] and [Ca2+]i: (1) inhibition of IP3
generation through PKC-mediated inactivation of agonist receptors or PLC; (2) Ca2+-mediated activation of IP3 removal
by ITPK; and (3) activation of PLC by Ca2+ (see Politi et al.,
2006 and Sneyd et al., 2006). We have investigated how a
molecular IP3 buffer (e.g., GFP-LBD) is predicted to affect
these oscillator mechanisms by analyzing prototypical mathematical models for each mechanism. The models incorporate
the regulatory properties of the IP3R (stimulation by IP3
and activation and delayed inhibition by [Ca2+]i) together
with one of the above-mentioned feedback mechanisms
(Figure S5).
In the absence of IP3 buffer, all models reproduce the experimentally observed encoding of agonist dose into [Ca2+]i
oscillation frequency (Figures 5A–5D). This result shows that
fundamentally different oscillator mechanisms can account
for the data. However, the introduction of an IP3 buffer
(at concentrations achieved for GFP-LBD; Table S1) reveals
qualitative differences between the models. In the negativefeedback models (1 and 2), the IP3 buffer decreased oscillation

frequency and increased the latency to first spike (Figures 5E
and 5F), but the oscillations persisted even at very high
concentrations of IP3 buffer (30 mM). By contrast, in the positive-feedback model with Ca2+-activated PLC, IP3 buffer
(5 mM) completely abolished oscillations. Instead, stepwise increases of [Ca2+]i with increasing agonist concentrations were
observed (Figure 5G) that closely resemble the experimental
observations in COS cells (Figure 1). In this model, plasmamembrane Ca2+ fluxes were neglected, assuming that they
are small relative to the fluxes across the ER membrane.
When substantial Ca2+ fluxes through the plasma-membrane
Ca2+ ATPase were added to the model, the IP3 buffer converted [Ca2+]i oscillations into slow and broad responses
to agonist stimulation (Figure 5H) that are similar to those
observed in hepatocytes (Figure 2). For lower concentrations
of IP3 buffer (1 mM), the oscillations persisted but had lower
frequencies (not shown).
In summary, negative-feedback models involving either PKC
or ITPK cannot account for the experimentally observed effects
of GFP-LBD. By contrast, the positive-feedback model with Ca2+
activation of PLC reproduces the distinct patterns of broadened
[Ca2+]i oscillations and amplitude-modulated stepwise [Ca2+]i
increases observed in the presence of the IP3 buffer in hepatocytes and COS cells. This provides further evidence that IP3
dynamics are an intrinsic component of the Ca2+ oscillator, at
least for these cell types.
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DISCUSSION
We have used engineered IP3-binding proteins expressed in
intact cells to investigate the effects of slowing [IP3] dynamics
on hormone-induced [Ca2+]i oscillations. Apart from possible
effects on the initial Ca2+ spike, IP3 buffers are not expected to
substantially affect [Ca2+]i oscillator mechanisms that depend
only on a static increase in [IP3] (e.g., CICR at the IP3R). By
contrast, IP3 buffering is expected to perturb the ongoing
generation of repetitive [Ca2+]i spikes that depend on rapid
modulation of IP3 levels to sustain the oscillatory behavior (e.g.,
cross-coupling between Ca2+ and IP3). Thus, IP3 buffers can be
used as an experimental tool to examine the causality between
IP3 dynamics and Ca2+ oscillations. Moreover, computational
studies have shown that an IP3 buffer can be used to distinguish
the type of Ca2+-dependent feedback (positive versus negative)
on IP3 metabolism, because these mechanisms predict qualitatively different effects of IP3 buffering (Politi et al., 2006).
Expression of molecular IP3 buffers in hepatocytes and COS
cells suppressed or eliminated oscillatory [Ca2+]i signals in a concentration-dependent manner. The IP3R ligand-binding domain
constructs used here did not directly affect intracellular Ca2+
release or plasma membrane Ca2+ entry mechanisms. The effects on [Ca2+]i oscillations were specific for GFP-LBD binding
to IP3 because the nonbinding mutant R265QLBD had no
effect. Importantly, these IP3 buffering effects were not restricted
to the initial phase of the oscillations but were observed for
the first [Ca2+]i spike and all of the subsequent spikes in the
oscillation train. The fact that IP3 buffering affected these later
Ca2+ oscillations is a clear indication of the importance of IP3
dynamics during ongoing Ca2+ spiking.
Simultaneous direct measurement of [IP3] and [Ca2+]i revealed
synchronized oscillations in both messengers during hormone
stimulation. Importantly, the fact that the IP3 buffer slowed the
rate of rise of both [Ca2+]i and [IP3] indicates that Ca2+ dynamics
are intimately tied to IP3 dynamics. Moreover, the effects of GFPLBD cannot be explained by a reduction in the steady-state or
time-averaged increase in free [IP3], because the peak [IP3] during each [Ca2+]i spike was unaffected and the perturbation of
[Ca2+]i and [IP3] kinetics persisted throughout the train of oscillations. GFP-LBD also slowed the falling phase of each [Ca2+]i
oscillation, which is consistent with the expected interplay between Ca2+ and IP3 in the cross-coupling PLC positive feedback
model (Politi et al., 2006). Thus, inactivation of the IP3R by Ca2+
negative feedback is insufficient to fully terminate Ca2+ release
until the [IP3] falls, and this process is slowed by the presence
of the IP3 buffer.
A slow, continuous photolysis of caged IP3 was used to mimic
the low hormone doses that typically induce Ca2+ oscillations in
hepatocytes. Although this slow IP3 uncaging could elicit a Ca2+
spike, the rates of Ca2+ rise were about 10-fold slower compared
to those recorded after VP stimulation and also had a significantly
lower amplitude. This can be explained by positive Ca2+ feedback
on PLC only occurring during hormone activation, whereas
the slow uncaging of IP3 in the absence of hormone does not
engage this positive feedback on IP3 generation. Importantly,
GFP-LBD did not affect the rate of rise or amplitude of Ca2+
increases triggered by the slow release of caged IP3, whereas

subsequent hormone-evoked Ca2+ oscillations were inhibited in
the same cell. These data indicate that the effects of GFP-LBD
expression on hormone-induced Ca2+ oscillations are not a simple consequence of the rate of delivery of IP3 to the IP3R to trigger
CICR. Instead, the qualitatively different effects of IP3 buffering
observed with hormone compared to IP3 uncaging demonstrate
the importance of positive feedback to regenerate IP3 during
hormone stimulation and show that IP3 dynamics are an essential
component sustaining baseline separated Ca2+ oscillations.
Finally, our observation that hepatocytes and COS cells expressing high levels of GFP-LBD did not exhibit agonist-induced [Ca2+]i
oscillations at all but instead responded with monophasic or
broad [Ca2+]i transients indicates that [Ca2+]i oscillations do not
occur in these cells in the absence of [IP3] oscillations.
Taken together, the data are consistent with a model in
which [IP3] oscillations, mediated by Ca2+-dependent feedback
on IP3 metabolism, are essential for repetitive, large-amplitude
[Ca2+]i spiking. Cross-coupling between Ca2+ and IP3 can occur
through either positive or negative feedback mechanisms. However, our experimental and computational studies indicate that
the results can only be reproduced with a positive feedback
mechanism, i.e., Ca2+-dependent activation of PLC. The IP3
buffer interferes by dampening and, at high concentration, abolishing the [IP3] oscillations. Accordingly, oscillatory [Ca2+]i spikes
are slowed and prolonged at low buffer concentration and
disappear at high buffer concentration.
In conclusion, this study presents evidence that Ca2+ feedback
regulation of the IP3R is not sufficient in itself to generate low-frequency, baseline-separated [Ca2+]i oscillations elicited by PLClinked hormones in hepatocytes and COS cells. Experimental
manipulation of IP3 dynamics with an IP3 buffer has provided
important insights into the mechanisms generating [Ca2+]i oscillations and waves. Our data are consistent with a model for [Ca2+]i
spiking that combines IP3-Ca2+ cross-coupling with IP3R-based
Ca2+ excitability. The combination of two coupled oscillators,
one at the level of IP3 generation/breakdown and the other at
the level of IP3R activation/inactivation, can greatly extend the
frequency range for encoding hormone stimulus strength in
[Ca2+]i oscillations (Politi et al., 2006). This provides a high-fidelity
signal, even at very low hormone doses, and is likely to be a
widely used paradigm to fine-tune responses to stimulation.
EXPERIMENTAL PROCEDURES
Cells
COS-7 cells obtained from American Type Culture Collection were cultured
in Dulbecco’s modified Eagle’s medium plus 10% fetal bovine serum. Hepatocytes were isolated by collagenase perfusion of rat livers and maintained in
primary culture for 16–20 hr in Williams E medium (Hajnóczky et al., 1995;
Rooney et al., 1989). Animal studies were approved by Rutgers New Jersey
Medical School Institutional Animal Care and Use Committee.
GFP-LBD Expression and IP3 Binding
Rat type 1 IP3R cDNA encoding LBD, residues 1–620, and R265QLBD
were ligated in frame to the C terminus of pGFP-C1 or pDsRed-C1 (Clontech
Laboratories) to generate the plasmids pGFP-LBD, pDsRed-LBD, and
pGFP-R265QLBD. Cells were transfected 16–48 hr prior to use. Expression
of recombinant protein was confirmed by western blot analysis with antiGFP antibody. Confocal microscopy was used to calculate the intracellular
[GFP] as described previously (Politi et al., 2006). Quantitation of IP3-binding
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sites in lysates of transfected COS cells was determined using [3H]-IP3 (Joseph
et al., 1995). Agonist-induced formation of IP3 in intact COS cells was
measured using a commercial IP3 mass assay (GE Healthcare).
Ca2+ and IP3 Imaging
Live-cell imaging was performed with cells plated on glass coverslips. Fura-2
or Indo-1 were loaded as acetoxymethyl esters for 20–40 min. RGECO1
(Addgene) or IRIS-1 (gift of K. Mikoshiba, RIKEN Brain Science Institute)
were cotransfected with the LBD constructs as required. The cells were
incubated in HEPES-buffered physiological saline solution in a microscope
chamber maintained at 37 C. Properties of [Ca2+]i oscillations and waves
were determined as described previously (Hajnóczky and Thomas, 1997;
Rooney et al., 1989, 1990).
Model Description
The mathematical models (Figure S5) used to compute the time courses of IP3
concentration, P; [Ca2+ ]i, c; the free Ca2+ concentration in the ER, s; and the
fraction of active IP3Rs, r, for the negative-feedback and positive-feedbackgenerated [Ca2+]i spiking are described in the Supplemental Information.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and two tables and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2014.10.033.
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Thomas, A.P., Bird, G.S., Hajnóczky, G., Robb-Gaspers, L.D., and Putney,
J.W., Jr. (1996). Spatial and temporal aspects of cellular calcium signaling.
FASEB J. 10, 1505–1517.

Bartlett, P.J., Gaspers, L.D., Pierobon, N., and Thomas, A.P. (2014). Calciumdependent regulation of glucose homeostasis in the liver. Cell Calcium 55,
306–316.
Berridge, M.J. (1993). Inositol trisphosphate and calcium signalling. Nature
361, 315–325.
De Young, G.W., and Keizer, J. (1992). A single-pool inositol 1,4,5-trisphosphate-receptor-based model for agonist-stimulated oscillations in Ca2+
concentration. Proc. Natl. Acad. Sci. USA 89, 9895–9899.
Dupont, G., and Goldbeter, A. (1993). One-pool model for Ca2+ oscillations
involving Ca2+ and inositol 1,4,5-trisphosphate as co-agonists for Ca2+
release. Cell Calcium 14, 311–322.
Dupont, G., Koukoui, O., Clair, C., Erneux, C., Swillens, S., and Combettes, L.
(2003). Ca2+ oscillations in hepatocytes do not require the modulation of
InsP3 3-kinase activity by Ca2+. FEBS Lett. 534, 101–105.
Dupont, G., Combettes, L., Bird, G.S., and Putney, J.W. (2011). Calcium oscillations. Cold Spring Harb. Perspect. Biol. 3, pii: a004226.
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